IP Library Granted Patent US 8,142,774
Granted Patent B2
US 8,142,774 · App. 12/791,333 · Granted Mar 27, 2012

Methods of treatment using electromagnetic field stimulated stem cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,142,774
App. No.
12/791,333
Granted
Mar 27, 2012
Kind
B2
Abstract

Methods of modifying stem cells and compositions of modified stem cells, in particular mesenchymal stem cells, using electric or electromagnetic fields. In various embodiments, the present invention's methods are for the treatment of a human or other mammal subject in need thereof, comprising providing an in vitro culture comprising mesenchymal stem cells, administering an electric stimulation to the in vitro culture, and implanting the mesenchymal stem cells into the subject. Methods also include treatment of a human or other mammal subject, comprising implanting mesenchymal stem cells into the subject, and administering an electric stimulation to the mesenchymal stem cells in situ. Other embodiments include methods of administering electric stimulation in conjunction with growth factors to stem cells.

Claims (9)

1. A method of treatment of a human or other mammalian subject having a bone defect in need of enhanced bone formation, comprising:

collecting and isolating mesenchymal stem cells from said subject,

implanting the mesenchymal stem cells into the subject at the site of said defect,

administering an amount of bone morphogenic protein-2 (BMP-2) at the site of said defect to induce differentiation of said mesenchymal stem cells into osteoblasts, and administering an electric stimulation comprising a pulsed electromagnetic field to the mesenchymal stem cells in situ,

wherein said electric stimulation potentiates the differentiation of said mesenchymal stem cells induced by said amount of BMP-2, forming bone at the site of said defect, with the result being more efficacious than either administering electrical stimulation or BMP-2 independently of one another.

2. The method according to claim 1 , further comprising implanting osteoconductive granules at said site.

3. The method according to claim 1 , wherein said defect is a bone disease, fracture, wound, injury, birth defect, spinal fusion, defective cartilage, a site of an orthopedic implant, a degenerated or herniated intervertebral disk, site of intervertebral disk replacement, or spinal cord injury.

4. The method according to claim 1 , further comprising implanting a scaffold material at said site.

5. The method according to claim 1 , wherein the mesenchymal stem cells are concentrated prior to the implanting.

Assignments (4)
PARTIAL RELEASE OF SECURITY INTEREST IN PATENTS Recorded May 29, 2025
From: CERBERUS BUSINESS FINANCE AGENCY, LLC
To: EBI, LLC
Reel/Frame 071461/0989 →
RELEASE OF SECURITY INTEREST Recorded Apr 2, 2024
From: JPMORGAN CHASE BANK, N.A.
To: EBI, LLC; ZIMMER BIOMET SPINE, LLC (F/K/A ZIMMER BIOMET SPINE, INC.)
Reel/Frame 066973/0833 →
GRANT OF A SECURITY INTEREST -- PATENTS Recorded Apr 1, 2024
From: ZIMMER BIOMET SPINE, LLC; EBI, LLC
To: CERBERUS BUSINESS FINANCE AGENCY, LLC
Reel/Frame 066970/0806 →
SECURITY INTEREST Recorded Mar 2, 2022
From: BIOMET 3I, LLC; EBI, LLC; ZIMMER BIOMET SPINE, INC.; ZIMMER DENTAL INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 059293/0213 →